Aura Biosciences AURA Cash Flow Statement (2020-2026)

NASDAQ AURA
$6.47 -0.09 (-1.37%)
As of: Oct 21, 2026 · 10:59 AM EDT
Reported Financials

Aura Biosciences Quarterly Cash Flow Statement

Periods 24 quarters
Latest Jun 2026

Aura Biosciences reported cash from operations of -$32.50M and free cash flow of -$32.52M for the quarter ended Jun 2026, down 56.5% year over year. This cash flow statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-8.84M-11.63M-12.84M-13.47M-15.90M-16.56M-17.47M-18.30M-18.51M-22.13M-19.71M-20.34M-21.04M-25.83M-27.48M-27.02M-26.13M-25.56M-33.69M-45.64M
Depreciation and DepletionDep. & Depletion
0.20M0.23M0.30M0.30M0.30M0.30M0.33M0.30M0.40M0.30M0.31M0.30M0.30M0.29M0.30M0.30M0.30M0.23M0.30M0.30M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.20M0.23M0.30M0.30M0.30M0.30M0.33M0.30M0.40M0.30M0.31M0.30M0.30M0.29M0.30M0.30M0.30M0.23M0.30M0.30M
Share-based CompensationStock Comp.
0.55M1.30M1.59M1.29M1.71M1.81M1.91M1.93M2.33M2.60M2.91M3.13M2.75M2.94M3.51M3.83M3.69M3.28M3.82M12.37M
Gains from Sales and DivestituresGains Divest
0.01M-0.31M0.63M-0.21M
Gains from Investment SecuritiesGains Investment
0.01M0.14M0.16M0.23M1.00M1.03M0.82M1.14M1.51M1.32M1.07M0.77M0.50M0.28M0.34M0.42M0.29M0.34M
Other non-cash itemsOther Non-Cash
0.00M0.01M0.04M-0.06M0.32M0.66M0.33M0.34M0.45M0.72M0.35M0.36M0.40M0.37M0.40M0.38M0.39M0.40M0.41M0.44M
Change in Working Capital
Change in Account PayablesChange Payables
-0.72M0.16M-0.76M-0.76M0.84M1.02M-1.88M-0.50M0.89M0.46M0.02M-0.54M0.69M0.31M-0.30M-0.72M0.60M-0.43M1.02M-0.33M
Change in Accured ExpensesChange Accured Exp.
1.11M0.85M-1.83M1.43M1.34M-0.70M-0.51M1.27M1.04M1.51M-2.90M1.35M3.14M-0.02M-2.48M3.39M3.35M-0.12M-2.75M3.17M
Change in Other Operating AssetsOther Assets Change
0.96M3.01M1.66M-0.77M-0.48M3.27M-2.09M-1.57M0.87M-0.70M3.69M-1.20M0.50M0.92M-3.52M0.31M1.63M-2.49M-1.68M2.04M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.20M-0.25M-0.22M-0.22M-0.25M-0.63M-0.24M-0.29M0.05M-0.32M-0.33M-0.33M-0.36M-0.38M-0.39M-0.40M
Other Working Capital ChangesOther WC Changes
-0.96M-3.01M-1.66M0.77M0.28M-3.52M1.87M1.35M-1.11M0.06M-3.93M0.92M-0.45M-1.24M3.20M-0.64M-1.98M2.11M1.30M-2.44M
Other Operating ActivitiesOther Ops.
0.00M0.02M0.05M-0.05M-0.11M0.34M0.00M-0.01M0.03M
Cash from OperationsCash from Ops.
-8.69M-12.09M-15.20M-10.63M-10.76M-18.01M-16.41M-14.65M-15.40M-17.39M-24.45M-16.13M-15.27M-23.95M-23.36M-20.77M-20.14M-20.47M-29.89M-32.50M
Investing Activities
Capital ExpendituresCapex
0.57M0.82M0.60M0.07M0.06M0.36M0.11M0.19M0.09M0.32M0.09M0.53M0.34M0.30M0.19M0.04M0.05M0.18M0.10M0.02M
Change in Property, Plant and EquipmentChange in PP&E
-0.57M-0.82M-0.60M-0.07M-0.06M-0.36M-0.11M-0.19M-0.09M-0.32M-0.09M-0.53M-0.34M-0.30M-0.19M-0.04M-0.05M-0.18M-0.10M-0.02M
Purchase of InvestmentsInvestments Purchased
24.90M46.37M48.52M88.85M144.80M29.20M9.90M20.00M9.98M73.97M
Sale and Maturity of InvestmentsInvestments Sold
18.00M32.01M22.08M21.60M21.72M55.00M168.14M30.00M30.00M30.00M30.00M30.00M55.00M30.00M
Cash from Investing ActivitiesCash from Investing
-0.57M-0.82M-25.50M-43.44M17.95M-16.88M-66.88M21.41M21.63M-90.12M9.40M19.84M9.89M29.70M29.81M19.98M-44.02M29.82M54.90M-226.04M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
0.02M78.74M0.02M0.31M0.10M86.65M0.20M0.66M0.27M92.99M0.25M0.08M0.72M0.54M0.10M60.68M1.08M0.30M280.85M
Net Shares Issued and RepurchasedNet Shares Issued
0.02M78.74M0.02M0.31M0.10M86.65M0.20M0.66M0.27M92.99M0.25M0.08M0.72M0.54M0.10M60.68M1.08M0.30M280.85M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.02M78.74M0.02M0.31M0.10M86.65M0.20M0.66M0.27M92.99M0.25M0.08M0.72M0.54M0.10M60.68M1.08M0.30M280.85M
Other financing activitiesOther financing
-1.14M1.40M
Cash from Financing ActivitiesCash from Financing
-1.12M80.14M0.02M0.31M0.10M95.20M0.20M2.48M1.63M92.99M0.25M0.08M0.72M0.54M0.10M69.93M4.36M2.77M0.30M241.75M
Additional items
Exchange Rate EffectFX Effect
-0.02M0.01M-0.01M-0.16M-0.03M-0.17M
Change in Cash
-10.38M67.24M-40.68M-53.76M7.29M60.31M-83.09M9.24M7.85M-14.52M-14.80M3.80M-4.67M6.29M6.55M69.13M-59.80M12.12M25.31M-16.78M
Ending Cash Balance
81.97M149.21M108.53M54.77M62.06M122.37M39.28M48.52M56.37M41.85M27.05M30.84M26.18M32.46M38.99M108.14M48.32M60.28M85.56M68.60M
Free Cash FlowFCF
-9.26M-12.91M-15.80M-10.70M-10.82M-18.37M-16.52M-14.84M-15.49M-17.70M-24.54M-16.65M-15.61M-24.25M-23.54M-20.81M-20.19M-20.65M-30.00M-32.52M
Net Cash FlowNCF
-10.38M67.24M-40.68M-53.76M7.29M60.31M-83.09M9.24M7.85M-14.52M-14.80M3.80M-4.67M6.29M6.55M69.13M-59.80M12.12M25.31M-16.78M

Aura Biosciences Cash Flow Statement API

Pull Aura Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=AURA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY